These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy. Takeishi Y; Fujiwara S; Atsumi H; Takahashi K; Sukekawa H; Tomoike H J Nucl Med; 1997 Sep; 38(9):1407-11. PubMed ID: 9293798 [TBL] [Abstract][Full Text] [Related]
48. Intra-individual comparison of 3(R)-BMIPP and 3(S)-BMIPP isomers in humans. Caveliers V; Franken PR; Lin Q; Mokler FT; Luo H; Knapp FF J Nucl Med; 1998 Oct; 39(10):1672-5. PubMed ID: 9776266 [TBL] [Abstract][Full Text] [Related]
49. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. Tamaki N; Kawamoto M; Yonekura Y; Fujibayashi Y; Takahashi N; Konishi J; Nohara R; Kambara H; Kawai C; Ikekubo K J Nucl Med; 1992 May; 33(5):659-67. PubMed ID: 1569474 [TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics and metabolism of the methyl-branched fatty acid (BMIPP) in animals and humans. Kropp J; Eisenhut M; Ambrose KR; Knapp FF; Franke WG J Nucl Med; 1999 Sep; 40(9):1484-91. PubMed ID: 10492369 [TBL] [Abstract][Full Text] [Related]
51. Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. Nagaya N; Goto Y; Satoh T; Uematsu M; Hamada S; Kuribayashi S; Okano Y; Kyotani S; Shimotsu Y; Fukuchi K; Nakanishi N; Takamiya M; Ishida Y J Nucl Med; 1998 Oct; 39(10):1676-80. PubMed ID: 9776267 [TBL] [Abstract][Full Text] [Related]
52. Absent myocardial I-123 BMIPP uptake in a family. Hwang EH; Yamashita A; Takemori H; Taki J; Nakajima K; Bunko H; Nakamura S; Ikeda T; Tonami N Ann Nucl Med; 1996 Nov; 10(4):445-8. PubMed ID: 9006733 [TBL] [Abstract][Full Text] [Related]
53. [Evaluation of myocardial uptake of beta-methyl-(123I)-iodophenylpentadecanoic acid (123I-BMIPP)]. Momose M; Kobayashi H; Saito K; Matsumoto N; Maki M; Hosoda S; Kusakabe K Kaku Igaku; 1994 Dec; 31(12):1519-23. PubMed ID: 7861651 [TBL] [Abstract][Full Text] [Related]
54. Type I CD36 deficiency associated with metabolic syndrome and vasospastic angina: a case report. Kamiya M; Nakagomi A; Tokita Y; Yasutake M; Kusama Y; Takayama M; Takano T J Cardiol; 2006 Jul; 48(1):41-4. PubMed ID: 16886497 [TBL] [Abstract][Full Text] [Related]
55. Effect of metabolic substrate on BMIPP metabolism in canine myocardium. Nohara R; Hosokawa R; Hirai T; Okuda K; Ogino M; Fujibayashi Y; Fujita M; Sasayama S J Nucl Med; 1998 Jul; 39(7):1132-7. PubMed ID: 9669382 [TBL] [Abstract][Full Text] [Related]
56. Takotsubo-shaped cardiomyopathy with type I CD36 deficiency. Kushiro T; Saito F; Kusama J; Takahashi H; Imazeki T; Tani S; Kikuchi S; Imai S; Matsudaira K; Watanabe I; Hino T; Sato Y; Nakayama T; Nagao K; Kanmatsuse K Heart Vessels; 2005 May; 20(3):123-5. PubMed ID: 15912310 [TBL] [Abstract][Full Text] [Related]
57. Effects of configuration on the myocardial uptake of radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in rats. Lin Q; Luo H; Mokler F; Beets AL; Ambrose KR; McPherson DW; Kropp J; Knapp FF J Nucl Med; 1997 Sep; 38(9):1434-41. PubMed ID: 9293804 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans. Sloof GW; Visser FC; van Lingen A; Bax JJ; Eersels J; Teule GJ; Knapp FF Nucl Med Commun; 1997 Nov; 18(11):1065-70. PubMed ID: 9423207 [TBL] [Abstract][Full Text] [Related]
59. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. Tanaka T; Nakata T; Oka T; Ogawa T; Okamoto F; Kusaka Y; Sohmiya K; Shimamoto K; Itakura K J Lipid Res; 2001 May; 42(5):751-9. PubMed ID: 11352982 [TBL] [Abstract][Full Text] [Related]